tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alex Thompson, 126 are a BUY (83.44%), 25 are a HOLD (16.56%).
Analyst Alex Thompson, currently employed at STIFEL, carries an average stock price target met ratio of 52.51% that have a potential upside of 50.93% achieved within 153 days.
Alex Thompson’s has documented 297 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KYMR, Kymera Therapeutics at 22-Sep-2026.
Analyst best performing recommendations are on CRNX (CRINETICS PHARMACEUTICALS).
The best stock recommendation documented was for CRNX (CRINETICS PHARMACEUTICALS) at 6/22/2026. The price target of $83 was fulfilled within 15 days with a profit of $47.62 (134.6%) receiving and performance score of 89.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Aug-2023
$48
$0.45 (0.95%)
$48
3 years 2 months 12 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold Since 26-Jun-2023
$56
3 years 3 months 25 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Buy Since 22-May-2023
$48
3 years 4 months ago
(21-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Buy Since 14-Sep-2022
$48
$0.45 (0.95%)
$68
3 years 4 months 1 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold Since 24-May-2023
$48
$0.45 (0.95%)
$38
3 years 4 months 1 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Which stock is Alex Thompson most bullish on?
Which stock is Alex Thompson most reserved on?
What Year was the first public recommendation made by Alex Thompson?
